跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,472 条关于
“Siglec-10”
全部
21,472
临床试验
12,934
药物
1,159
机构
156
资讯
7,223
5个月前
OncoC4 Initiates First-in-Class Anti-SIGLEC 10 Antibody Trial for Alzheimer's Disease Treatment
去年
OncoC4's ONC-841 Shows Promise as First-in-Class Alzheimer's Disease Immunotherapy in Preclinical Studies
5个月前
Pheast Therapeutics Advances PHST001 Anti-CD24 Antibody into Phase 1b Combination Trials
前天
FDA Grants Fast Track Designation to OncoC4's PD-1/VEGF Bispecific Cesalatamig for PD-(L)1-Refractory NSCLC
11个月前
University of Galway Researchers Discover Sugar-Coating Mechanism That Helps Bowel Cancer Evade Immune System
去年
Pheast Therapeutics Initiates Phase 1 Trial of Novel Anti-CD24 Macrophage Checkpoint Inhibitor for Advanced Solid Tumors
上个月
OncoC4 Doses First Patient in Phase 1 Trial of ONC-783, First-in-Class T-Cell Engager Targeting neoCD24
2年前
Aviceda Therapeutics Advances AVD-104 for Geographic Atrophy with Phase II/III Trial
去年
Aviceda Therapeutics Completes Enrollment in Phase 2b SIGLEC Study of AVD-104 for Geographic Atrophy
去年
Aviceda Therapeutics Completes Enrollment in Phase 2b SIGLEC Study of AVD-104 for Geographic Atrophy
第 1 页,共 723 页
上一页
下一页